Philip R Tedbury

18PUBLICATIONS
59CO-AUTHORS
Toxicology (incl. clinical toxicology)Medical molecular engineering of nucleic acids and proteinsMedical devicesGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 09, 2026
Structural, biophysical, and virological mechanistic characterization of HIV-1 capsid-targeting antivirals.

Karen A Kirby, William M McFadden, Lei Wang

|Jun 06, 2025
Strategy to overcome a nirmatrelvir resistance mechanism in the SARS-CoV-2 nsp5 protease.

Grace Neilsen, Shuiyun Lan, Ryan L Slack

|Dec 16, 2024
Disruption of LEDGF/p75-directed integration derepresses antisense transcription of the HIV-1 genome.

Philip R Tedbury, Darius Mahboubi, Maritza Puray-Chavez

|Oct 28, 2023
HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes.

Maria E Cilento, Xin Wen, Aaron B Reeve

|Oct 06, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.

Philip R Tedbury, Candela Manfredi, Frauke Degenhardt

|Feb 25, 2023
SARS-CoV-2 Induces Epithelial-Enteric Neuronal Crosstalk Stimulating VIP Release.

Arun Balasubramaniam, Philip R Tedbury, Simon M Mwangi

Pageof 3

Frequent Collaborators

5 joint publications

Karen A Kirby

5 joint publications

Stefan G Sarafianos

4 joint publications

Zhengqiang Wang

2 joint publications

Andrew D Huber